<DOC>
	<DOC>NCT00681694</DOC>
	<brief_summary>The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.</brief_summary>
	<brief_title>Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer</brief_title>
	<detailed_description>Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Pathological diagnosis of an adenocarcinoma of the prostate 18 years of age or older Prior choice of either standard brachytherapy or MRIGPB as primary treatment Prior primary therapy (surgery or external beam radiation) for prostate cancer Current hormone ablation therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>brachytherapy</keyword>
	<keyword>radioactive seed implants</keyword>
</DOC>